鲍曼不动杆菌对氨基糖苷类药物耐药机制研究

摘要/Abstract

摘要： 目的　研究对氨基糖苷类抗菌药物耐药的鲍曼不动杆菌分子流行病学特征和耐药机制。方法　采用琼脂稀释法检测抗菌药物对鲍曼不动杆菌的最低抑菌浓度（MIC），采用肠杆菌科基因间重复一致性序列（ERIC）-聚合酶链反应（PCR）研究耐药菌株的分子流行病学特征，采用特异性PCR、序列分析和接合试验研究介导耐药的分子机制。结果　临床分离菌株对包括氨基糖苷类抗菌药物在内的多种药物广泛耐药，同源性分析显示属于7个流行克隆型。所有分离菌株均扩增出介导氨基糖苷类抗菌药物耐药的修饰酶和药物“外排泵”基因，部分菌株扩增出甲基化酶基因。结论　修饰酶和甲基化酶介导鲍曼不动杆菌临床分离株对氨基糖苷类药物耐药，药物“外排泵”参与介导耐药机制形成，垂直传播和通过耐药性质粒的水平传递可能是耐药菌株播散的主要方式。

关键词: 色氨酸, 犬尿氨酸, 犬尿喹啉酸, 吲哚胺2;3-双加氧酶, 犬尿氨酸氨基转移酶, 原发性高血压

Abstract: Objective　To investigate the molecular epidemiology and mechanism of aminoglycoside resistance to Acinetobacter baumannii isolates. Methods　Agar-dilution was carried out to detect the minimum inhibitory concentration（MIC）, and enterobacterial repetitive intergenic consensus（ERIC）-polymerase chain reaction（PCR） was performed to analyze the molecular epidemiology of aminoglycoside-resistance isolates. Specific PCR，DNA sequencing，conjugation experiments were carried to confirm the transmission mechanism. Results　All the clinical isolates were resistant to most drugs including aminoglycosides, and ERIC-PCR showed the isolates belonged to 7 genotypes. Specific PCR and DNA sequencing revealed that all isolates encoded aminoglycoside-modifying enzyme genes, efflux pump gene and methylase gene. Conclusions　Producing of aminoglycoside-modifying enzyme and methylase mainly contribute to reduce the susceptibility of aminoglycosides in Acinetobacter baumannii. Efflux pump overexpression may as a cofactor in high-level aminoglycoside resistance. Vertical transmission and plasmid-mediated horizontal transmission are probably the principal epidemical mechanisms.

Key words: Tryptophan, Kynurenine, Kynurenic acid, Indoleamine 2;3-dioxygenase, Kynurenine aminotransferase, Essential hypertension

蒯守刚;黄利华;裴　豪;王　旭;何琳静;刘　君. 鲍曼不动杆菌对氨基糖苷类药物耐药机制研究[J]. 检验医学, 2012, 27(8): 619-623.

参考文献

[1]Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically[S]. 20th ed. M7-A8, CLSI，2010.
[2]魏华，孙立国，朱　晶，等. 不同的DNA提取法对两种常见医院感染菌ERIC-PCR鉴定的影响研究[J].中华医院感染学杂志，2007，17（9）：1044-1047.
[3]Valdezate S，Vindel A，Echeita A，et al. Topoisomerase Ⅱ and Ⅳ quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility[J]. Anti-microb Agents Chemother，2002，46（3）：665-671.
[4]Peleg AY，Seifert H，Paterson DL. Acinetobacter baumannii：emergence of a successful pathogen[J]. Clin Microbiol Rev，2008，21（3）：538-582.
[5]Zarrilli R，Giannouli M，Tomasone F，et al. Carba-penem resistance in Acinetobacter baumannii：the molecular epidemic features of an emerging problem in health care facilities[J]. J Infect Dev Ctries，2009，3（5）：335-341.
[6]〖JP2〗Yu FY，Yao D，Pan JY，et al. High prevalence of plasmid-mediated 16S rRNA methylase gene rmtB among Escherichia coli clinical isolates from a Chinese teaching hospital[J]. BMC Infect Dis，2010，10：184.
[7]Doi Y，Adams JM，Yamane K，et al. Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America[J]. Antimicrob Agents Chemother，2007，51（11）：4209-4210.
[8]Yu YS，Zhou H，Yang Q，et al. Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China[J]. J Antimicrob Chemother，2007，60（2）：454-455.
[9]〖JP2〗余方友，陈　婵，杜卫良，等. 质粒介导16S rRNA甲基化酶肺炎克雷伯菌临床分离株的检测及分子流行病学研究[J]. 中华检验医学杂志，2009，32（3）：268-273.
[10]〖JP3〗Higgins PG，Wisplinghoff H，Stefanik D，et al. Selection of topoisomerase mutations and over-
expression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii[J]. J Antimicrob Chemother，2004，54（4）：821-823.
[11]蒯守刚，邵海枫. 不动杆菌耐药机制研究进展[J]. 中国实验诊断学，2009，13（2）：278-280.
[12]〖JP2〗Hornsey M，Ellington MJ，Doumith M，et al. AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii[J]. J Antimicrob Chemother，2010，65（8）：1589-1593.
[13]Nemec A，Maixnerova M. Aminoglycoside resistance of Acinetobacter baumannii hospital strains in the Czech Republic[J]. Klin Mikrobiol Infekc Lek，2004，10（5）：223-228.
[14]Luo L，Jiang X，Wu Q，et al. Efflux pump over-expression in conjunction with alternation of outer membrane protein may induce Acinetobacter baumannii resistant to imipenem[J]. Chemotherapy，2011，57（1）：77-84.
[15]Sun JR，Chan MC，Chang TY，et al. Overexpression of the aseB gene in clinical isolates of tigecycline-nonsusceptible Acinetobacter baumannii without insertion mutations in adeRS[J]. Antimicrob Agents Chemother，2010，54（11）：4934-4938.